ClinicalTrials.Veeva

Menu

The Impact of "Natural" Cesarean Delivery on Peripartum Maternal Blood Loss.

R

Raed Salim

Status

Completed

Conditions

Postpartum Hemorrhage

Treatments

Other: Natural cesarean delivery
Other: Standard cesarean delivery

Study type

Interventional

Funder types

Other

Identifiers

NCT02768142
00137-15-EMC

Details and patient eligibility

About

Throughout the history, the neonate was dependent on maternal touch and care for survival. In modern obstetrics, with hospital care the neonates are seldom separated from their mothers after delivery. Early skin to skin (ESTS) contact after delivery was found to increase milk production, lactation and improve maternal and neonatal outcome.

Oxytocin is the primary hormone responsible for uterine contraction and prevention of postpartum hemorrhage (PPH). ESTS contact increases oxytocin secretion.

The rate of cesarean deliveries (CDs) increased dramatically over the past decades. CD was found to decrease postpartum milk production, postpones early lactation and decreases exclusive breastfeeding.

During the typical CD, the neonate is usually presented for a short while to the mother and breastfeeding is usually delayed at least a number of hours until after the surgery and the recovery period.

Natural CD, enable ESTS contact during the surgery and give the mother the opportunity to start breastfeeding immediately after delivery of the neonate in the surgery suit. Oxytocin secretion increases with ESTS and during breastfeeding.

The aim of this study is to examine blood loss that occurs after Natural CD compared to standard CD without an ESTS contact.

Enrollment

214 patients

Sex

Female

Ages

8 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Estimated to be appropriate for gestational age fetus.
  • Sonographic dating before 20 weeks of gestation.

Exclusion criteria

  • Non-scheduled CD.
  • Major fetal malformations.
  • Multiple gestations.
  • Non-controlled diabetes.
  • Severe pre-eclampsia.
  • General anesthesia.
  • HIV carrier
  • Neonatal need for early resuscitation.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

214 participants in 2 patient groups

Natural cesarean delivery
Experimental group
Description:
Placing the neonate on maternal chest immediately after the extraction from the uterus, and permitting breastfeeding during surgery.
Treatment:
Other: Natural cesarean delivery
Standard cesarean delivery
Active Comparator group
Description:
Presentation of the neonate to the mother during the operation.
Treatment:
Other: Standard cesarean delivery

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems